Coronavirus: Bayer to increase its chloroquine production in Europe

Published by Rizhlaine de Sortiraparis · Published on April 13, 2020 at 12:44 p.m.
In Europe, pharmaceutical company Bayer is said to boost its production of medicines based on chloroquine in order to give them for free to governments as long as the crisis lasts.

While the coronavirus epidemic keeps on spreading in the world, the issue about using chloroquine as a medicine is still on the agenda. As for pharmaceutical companies such as Sanofi, some of them offer to donate medicines based on this anti-malaria medication.

As for German group Bayer, they have announced to boost the production of an ancient medicine in Europe, Resochin, a treatment against malaria based on chloroquine and created about 80 years ago. So far, its production was limited to one factory in Pakistan and the medicine was not longer available since last summer.

Yet, while the world is going though a health crisis related to the covid-19 pandemic, the use of chloroquine as a treatment sparks a debate. Earlier this week, French President Emmanuel Macron met professor Raoult known for his position in favor of using this medicine against coronavirus.

Bayer then wishes to help governments fight against this epidemic. By boosting the production of this chloroquine-based medication, the German group wishes to give it for free to countries as long as the epidemic lasts. The United-States are said to have received 3 million pills in late March.

Practical information
Comments
Refine your search
Refine your search
Refine your search
Refine your search